Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Gene therapy

Ocugen
Public Companies

Ocugen Secures Gene Therapy Licenses Ahead of Phase 3 Results

November 10, 2026November 9, 2026 - by Timothy Alexander

MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) has secured a Middle East and North Africa licensing agreement worth up to $259 million in potential payments and received provisional regulatory approval …

Ocugen Secures Gene Therapy Licenses Ahead of Phase 3 Results Read More

Latus Bio
Regional / Research

Latus Bio Reports Gene Delivery Gains in Brain, Kidney Studies

November 9, 2026November 9, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Latus Bio Inc. has reported preclinical advances in delivering gene therapies to brain and kidney cells, demonstrating improved targeting compared with conventional viral delivery technology as the …

Latus Bio Reports Gene Delivery Gains in Brain, Kidney Studies Read More
Latus Bio
Regional

Latus Bio Study Advances Gene Therapy Strategy for Huntington’s

November 8, 2026November 6, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Latus Bio Inc. has published research supporting a gene therapy approach that could slow Huntington’s disease progression by targeting a DNA repair protein linked to neuronal damage, …

Latus Bio Study Advances Gene Therapy Strategy for Huntington’s Read More

Latus Bio
Regional

Latus Bio Advances Gene Therapies for Brain and Kidney Diseases

October 25, 2026October 24, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Latus Bio is advancing experimental gene therapies for Huntington’s disease and CLN2 Batten disease while developing delivery technology intended to improve how genetic treatments reach brain, spinal …

Latus Bio Advances Gene Therapies for Brain and Kidney Diseases Read More
Ocugen
Public Companies

Ocugen CEO to Address Gene Therapy Commercialization

October 4, 2026October 3, 2026 - by Timothy Alexander

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) Chief Executive Officer Shankar Musunuri will discuss regulatory approval and commercialization of cell and gene therapies at an industry conference Oct. 6 in …

Ocugen CEO to Address Gene Therapy Commercialization Read More

Ocugen
Research

Ocugen Wins Bahamas Priority Path for OCU400 Gene Therapy

September 28, 2026September 25, 2026 - by Timothy Alexander

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has secured provisional approval and priority designation in The Bahamas for OCU400, creating a pathway to provide its investigational gene therapy to retinitis …

Ocugen Wins Bahamas Priority Path for OCU400 Gene Therapy Read More
U.S. Food and Drug Administration
Health / Medical / National

FDA Approves First Treatment for Sanfilippo Syndrome Type A

September 21, 2026September 21, 2026 - by Timothy Alexander

WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Fayuvi, a one-time gene therapy from Ultragenyx Pharmaceutical Inc., as the first treatment for children with mucopolysaccharidosis type IIIA, providing …

FDA Approves First Treatment for Sanfilippo Syndrome Type A Read More

Cencora
Regional

Cencora Expands Cell and Gene Therapy Support for Health Systems

September 12, 2026September 8, 2026 - by Timothy Alexander

CONSHOHOCKEN, PA — Cencora has launched a service to help health systems build and scale cell and gene therapy programs, targeting operational and financial barriers that can limit hospitals’ ability …

Cencora Expands Cell and Gene Therapy Support for Health Systems Read More
Ocugen
Research

Malvern’s Ocugen Starts Pivotal Trial for Eye Gene Therapy

September 6, 2026September 5, 2026 - by Timothy Alexander

MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) has dosed the first patient in a global Phase 3 trial of OCU410, moving its one-time gene therapy for geographic atrophy into pivotal …

Malvern’s Ocugen Starts Pivotal Trial for Eye Gene Therapy Read More
Ocugen
Research

FDA Gives Ocugen Gene Therapy Expedited Regulatory Status

August 5, 2026August 3, 2026 - by Timothy Alexander

MALVERN, PA — The U.S. Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation to Ocugen Inc.’s experimental OCU410 gene therapy for geographic atrophy, giving the blindness treatment access …

FDA Gives Ocugen Gene Therapy Expedited Regulatory Status Read More

Posts pagination

1 2 … 4 Next

Trending News

  • Tredyffrin/Easttown Plan Would Shift Elementary Boundaries

  • What Went Wrong at 7 Chester County Restaurants?

  • Camp Saginaw Withdraws New London Township Cell Tower Plan

  • Chadds Ford Art Museum Adds Outdoor Ice Rink for the Holidays

  • Coatesville Woman Pleads Guilty to Voting Illegally Twice

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Court News

Coatesville Woman Pleads Guilty to Voting Illegally Twice

November 20, 2026November 19, 2026

acw woman report

Pennsylvania Report Calls for Paid Leave, Workplace Reforms

November 20, 2026November 19, 2026

Courthouse

New York Man Accused of Supplying Cocaine to Penn State Fraternities

November 19, 2026November 19, 2026

Copyright © 2026 MyChesCo.